1. Home
  2. MAIA vs ASRV Comparison

MAIA vs ASRV Comparison

Compare MAIA & ASRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • ASRV
  • Stock Information
  • Founded
  • MAIA 2018
  • ASRV 1983
  • Country
  • MAIA United States
  • ASRV United States
  • Employees
  • MAIA N/A
  • ASRV N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • ASRV Major Banks
  • Sector
  • MAIA Health Care
  • ASRV Finance
  • Exchange
  • MAIA Nasdaq
  • ASRV Nasdaq
  • Market Cap
  • MAIA 46.7M
  • ASRV 40.3M
  • IPO Year
  • MAIA 2022
  • ASRV N/A
  • Fundamental
  • Price
  • MAIA $1.82
  • ASRV $2.51
  • Analyst Decision
  • MAIA
  • ASRV
  • Analyst Count
  • MAIA 0
  • ASRV 0
  • Target Price
  • MAIA N/A
  • ASRV N/A
  • AVG Volume (30 Days)
  • MAIA 341.6K
  • ASRV 20.6K
  • Earning Date
  • MAIA 05-09-2025
  • ASRV 04-22-2025
  • Dividend Yield
  • MAIA N/A
  • ASRV 4.78%
  • EPS Growth
  • MAIA N/A
  • ASRV N/A
  • EPS
  • MAIA N/A
  • ASRV 0.22
  • Revenue
  • MAIA N/A
  • ASRV $53,037,000.00
  • Revenue This Year
  • MAIA N/A
  • ASRV N/A
  • Revenue Next Year
  • MAIA N/A
  • ASRV N/A
  • P/E Ratio
  • MAIA N/A
  • ASRV $11.27
  • Revenue Growth
  • MAIA N/A
  • ASRV 16.87
  • 52 Week Low
  • MAIA $1.40
  • ASRV $2.03
  • 52 Week High
  • MAIA $5.99
  • ASRV $3.06
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 47.29
  • ASRV 61.76
  • Support Level
  • MAIA $1.80
  • ASRV $2.35
  • Resistance Level
  • MAIA $2.18
  • ASRV $2.46
  • Average True Range (ATR)
  • MAIA 0.29
  • ASRV 0.08
  • MACD
  • MAIA -0.03
  • ASRV 0.02
  • Stochastic Oscillator
  • MAIA 4.85
  • ASRV 100.00

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About ASRV AmeriServ Financial Inc.

AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.

Share on Social Networks: